Digital PCR Market By Technology (Droplet Digital Pcr, Chip Based Digital Pcr, Beaming Digital Pcr), By Product Type (Digital Pcr Systems, Consumables And Reagents, Software And Services), By Application (Research, Clinical Diagnostics, Forensic And Others), By End User (Pharmaceuticals And Biotechnology Industries, Clinical Diagnostic Laboratories, Universities And Other Organizations), : Global Opportunity Analysis and Industry Forecast, 2020-2030
The global digital PCR market was valued at $508.8 million in 2020, and is projected to reach $1,305.3 million by 2030, registering a CAGR of 8.6% from 2021 to 2030. Digital polymerase chain reaction (dPCR) is defined as an approach for the detection & quantification of nucleic acids that provides a sensitive and reproducible way to measure the amount of DNA or RNA present in a sample. dPCR exhibits high potential in research (basic research and applied research), clinical diagnostics, forensics, and other similar areas. dPCR systems are useful for copy number variation, rare sequence detection, mutation detection, miRNA analysis, gene expression analysis, and next-generation sequencing sample quantification.
The global digital polymerase chain reaction market is expected to register substantial growth in the near future owing to rise in prevalence of infectious diseases and increase in awareness & acceptance of personalized medicines. For instance, according to World Health Organization (WHO), around 1.5 million people died from tuberculosis in 2020 across the globe. Droplet digital PCR (ddPCR) is one of the analysis tests to detect the presence of mycobacterium tuberculosis. In addition, advancements in the technology in healthcare sector are anticipated to boost the market growth during the forecast period.
However, high cost of dPCR devices and reimbursement issues are the factors anticipated to hamper the market growth during the forecast period. Conversely, surge in funding for R&D activities in medical devices sector is expected to offer remunerative opportunities for market players. The digital polymerase chain reaction market is segmented into technology, product type, application, end user, and region. By technology, the market is categorized into droplet digital PCR (ddPCR), chip based digital PCR, and BEAMing digital PCR.
By product type, it is fragmented into digital PCR systems, consumables & reagents, and software & services. On the basis of application, it is segregated into research, clinical diagnostics, and forensic & others. As per end user, it is differentiated into pharmaceuticals & biotechnology industries, clinical diagnostic laboratories, and universities & other organizations. Region wise, it is analyzed across North America (U.S., Canada, and Mexico) Europe (Germany, France, UK, Italy, Spain, and rest of Europe) Asia-Pacific (Japan, China, Australia, India, South Korea, Taiwan, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players that operate in the global digital polymerase chain reaction market include Avance Biosciences, Bio-Rad Laboratories, Inc., Fluidigm Corporation, JN Medsys, Merck KGaA, PreciGenome LLC, Qiagen N.V, Stilla Technologies, Sysmex Corporation and Thermo Fisher Scientific, Inc.
KEY BENEFITS FOR STAKEHOLDERS
The report provides an in-depth analysis of the global digital PCR market size along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global digital PCR market growth.
Key Market Segments
By BY TECHNOLOGY
Droplet Digital Pcr
Chip Based Digital Pcr
Beaming Digital Pcr
By BY PRODUCT TYPE
igital Pcr Systems
Consumables And Reagents
Software And Services
By BY APPLICATION
Clinical Diagnostics
Forensic And Others
Research
By BY END USER
Pharmaceuticals And Biotechnology Industries
Clinical Diagnostic Laboratories
Universities And Other Organizations
By BY REGION
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan, Republic Of China
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
North America
U.S.
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Rest of Europe
Key Market Players
Avance Biosciences
Bio-Rad Laboratories, Inc.
Fluidigm Corporation
jn medsys
Merck KGAA
Precigenome LLC
QIAGEN N.V
STILLA TECHNOLOGIES
sysmex corporation
Thermo Fisher Scientific, Inc.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook